By Justin Petrone

Roche said this week that its Roche NimbleGen business will supply High-Throughput Genomics with arrays for use in gene-expression applications.

Under the terms of the deal, Roche NimbleGen will supply Tucson, Ariz.-based HTG with high-density, multiplex arrays. HTG plans to offer the arrays as part of its quantitative nuclease protection assays to enable researchers to rapidly measure gene expression levels in a variety of sample types, Roche said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.